Page 26 - Astrazeneca

AstraZeneca agrees to pay Japan's Daiichi $6 bn for new cancer drug

The UK drugmaker will pay Japan's Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, the companies said

More than enough doses of Covid-19 vaccine reserved for Parsis: Poonawalla

Serum Institute CEO didn't specify quantity of doses to be kept for community grappling with shrinking population

Adar Poonawalla: A rare risk-taking CEO with strong business acumen

Adar Poonawalla's Serum Institute has tied up with AstraZeneca-backed Oxford vaccine candidate for one billion doses which it will make for India and the GAVI vaccine alliance of 58 countries

Govt to ensure regulatory facilitation for Serum's Covid-19 vaccine trials

Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected

Covid-19 vaccine: Oxford candidate safe, shows immune response in trial

The preliminary results of the phase 1-2 trial, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and T-cells

Britain signs deals with Pfizer, BioNTech, Valneva for Covid-19 vaccines

Deals follow a previously announced agreement with AstraZeneca for the firm to produce 100 million doses of its potential vaccine being developed in partnership with the University of Oxford

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

Positive news on Oxford's Covid-19 vaccine may be announced on Thursday

AstraZeneca's experimental vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's chief scientist said in June

Covid-19: AstraZeneca to bring Dare-19 trial to India; 10 sites identified

Called the Dare 19 trial, it is one of the several global research efforts by the British company to find a solution to treat Covid-19

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

AstraZeneca says Brazil close to coronavirus vaccine deal for 100 mn doses

Brazil counts almost 58,000 dead by COVID-19, and more than 1.2 million cases of the disease

Covid-19: Brazil announces agreement with UK to produce Oxford vaccine

The Brazilian Ministry of Health announced an agreement with the UK to acquire technology to locally produce a Covid-19 vaccine currently being developed by the Oxford University and AstraZeneca

Astrazeneca leading in Covid-19 vaccine race, Moderna not far behind: WHO

Soumya Swaminathan said that Moderna's Covid-19 vaccine candidate was also not far behind Astrazeneca's, among more than 200 candidates

Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

Many drugmakers are racing to come up with a safe and effective vaccine that can be produced at large scale

Shot of Hope: Equal access a hurdle after race to coronavirus vaccine

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created

Shot of Hope: Tracking the race for Covid vaccine the world is waiting for

The first of a two-part series tracks the making of vaccine that the world is waiting for

AstraZeneca Covid-19 vaccine to be shared across Europe, says France

The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal

AstraZeneca signs pact with EU to supply 400 mn doses of Covid-19 vaccine

It has agreed manufacturing deals globally to meet its target of producing 2 billion doses of the vaccine, including two ventures backed by Bill Gates and a $1.2 billion agreement with the US govt